Examining the True Prevalence of Hypercortisolism and Its Impact on Managing Resistant Diabetes - Episode 4
True Prevalence of Hypercortisolism
The panel of medical experts discuss the prevalence of hypercortisolism based on the CATALYST trial.
Video content above is prompted by the following:
- What were the key findings from Part 1: Prevalence phase of the CATALYST study?
- How does the data from the CATALYST trial change the narrative about the true prevalence of hypercortisolism in diabetes?
- How does this prevalence data fit with the growing body of evidence regarding autonomous adrenal cortisol secretion?
- How would you respond to clinicians that reference “false positives” or “pseudo cushings” as an explanation to these findings?
